Interventional Catheterization in Adult Congenital Heart Disease
Open Access
- 27 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (12) , 1622-1633
Abstract
I mproved medical and surgical therapies for children with congenital heart disease have resulted in a growing population of patients reaching adulthood. 1,2 Over this same time, the field of interventional cardiology has experienced significant growth, driven by technological improvements and better understanding of the mechanisms and intermediateterm results of individual procedures. Consequently, for adults with uncorrected or previously palliated congenital heart disease, percutaneous therapies have increasing acceptance as reasonable additions, alternatives, and treatments of choice when further surgical or medical intervention is contemplated (Table 1). Currently, interventional cardiology of adult congenital heart disease (ACHD) is a wellestablished field on its own and, programmatically, is a fundamental component of any center providing care for these patients. 3 Although limited safety of interventional procedures for the ACHD population has been suggested in centers without ACHD global care programs, 4 the wide variation in clinical presentation, novelty of cardiovascular pathologies (with similarity to as well as marked differences from both congenital and acquired conditions), and potential for concomitant multiple organ system pathology all contribute to situations atypical for standard adult or pediatric laboratories. These concerns, combined with a desire to centralize data collection to establish outcomes assessments for ACHD patients considered for interventional catheterization, lead to the recommendation that such procedures be performed in centers with ACHD expertise and established care programs. 3 In this article, we review the most commonly performed percutaneous procedures in ACHD, including valvuloplasty, angioplasty, and device closures. We also include discussions concerning complex ACHD patients (Table 2) as well as future directions.Keywords
This publication has 41 references indexed in Scilit:
- Device Closure Rates of Simple Atrial Septal Defects Optimized by the STARFlex DeviceJACC, 2006
- Endovascular Stenting of Obstructed Right Ventricle–to–Pulmonary Artery ConduitsCirculation, 2006
- Percutaneous Interventional Closure of Large Pulmonary Arteriovenous Fistulas With the Amplatzer Duct OccluderThe American Journal of Cardiology, 2005
- Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defectsInternational Journal of Cardiology, 2005
- CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defectsAmerican Heart Journal, 2004
- Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluderJACC, 2004
- Pulmonary artery trauma due to balloon dilation: recognition, avoidance and managementJACC, 2000
- Use of echocardiography for detecting aortic valve leaflet avulsion and predicting repair potential after balloon valvuloplastyThe American Journal of Cardiology, 1995
- Balloon aortic valvuloplasty in the young adult with congenital aortic stenosisThe American Journal of Cardiology, 1994
- Balloon angioplasty for aortic recoarctation: Results of Valvuloplasty and Angioplasty of Congenital Anomalies RegistryThe American Journal of Cardiology, 1990